Loading clinical trials...
Loading clinical trials...
A Phase 3b, Randomized, Open-Label Study of HTX-011 as the Foundation of a Non-opioid, Multimodal Analgesic Regimen to Decrease Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
Conditions
Interventions
HTX-011
Luer lock applicator
+2 more
Locations
30
United States
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Horizon Clinical Research
La Mesa, California, United States
Sharp Grossmont Hospital
La Mesa, California, United States
University of California, Irvine Medical Center
Orange, California, United States
Parkview Community Hospital
Riverside, California, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Start Date
April 5, 2019
Primary Completion Date
October 25, 2021
Completion Date
November 22, 2021
Last Updated
February 21, 2022
NCT07242196
NCT07427043
NCT07420712
NCT07268911
NCT07310953
NCT07413848
Lead Sponsor
Heron Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions